Eating Disorders Blog

Approximately 50 percent of patients with a new cancer diagnosis and up to 70 percent of patients with advanced cancers may experience anorexia. A new study by Rudolph M. Navari, director of the University of Notre Dame's Walther Cancer Research Center, and Marie C. Brenner, a Notre Dame graduate who is a student at Loyola University Medical School in Chicago, indicates that a combination of two drugs shows promise in treating cancer-related anorexia (CRA). The researchers found that combining Olanzapine (Zyprexa) with megestrol acetate (MA) has resulted in weight gain for some patients suffering from CRA.

(Source: google.com/hostednews)

Labels: anorexia, cancer

Posted By: Aspen Education Group